Predizin 35mg tablets prolonged-release film-coated

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

trimetazidine (trimetazidine dihydrochloride)

Available from:

Gedeon Richter Poland Sp.z o.o.

ATC code:

C01EB15

INN (International Name):

trimetazidine (trimetazidine dihydrochloride)

Dosage:

35mg

Pharmaceutical form:

tablets prolonged-release film-coated

Units in package:

(60/6x10/) blisters

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2015-05-04

Summary of Product characteristics

                                \
06M.AN
XAPAKTEPUCTHKA
JIEKAPCTBA
1.
TOPRONOE UA3NAUUE:
IIPE,LT;II3HH®
Mex<,cyHapo,n;Hoe
HerraTeHToBaHHoe
Ha:maHHe
(MHH):
TpHMeT83H,D;HH
(trimetazidine)
2.
KOJIJIII'ICCTBEHHLIII
H
KA"IECTBCIIIILIII
COCTAN
KaxQJ;aJI
Ta6neTKa
co.n:ep)KHT:
_,l(eucmeyiOUJee _
_eeUJecmeo: _
TpHMeTa3H.n;HHa .n;Hrn:.n;pmmopH.n;
35
Mr
_BcnoMozameJlbHble _
_eeUJecmea: _
Jlnpo:
UCJIJIIOJI03a MHKpOKpHCTaJIJIHllCCKaJI,
KpaXMan
IIpe:>KeJiaTHHH3HpOBaHHI:.:lli,
rHIIpOMCJIJI03a,,
KpCMHIDI
.11:HOKCH.11:
KOJIJIOH.n;Hblli 6e3BO.n;HbiH,
MarHIDI
CTeapaT.
_06oJZollKa: _
OnanpaH:
II
Po30B:brli
85G24057
(rronHBHHHJIOBI:.lli
cnHpT
-
-qacTH'lliO
ru.n:pOJIH3HpOBaHHI:.lli,
TaJibK,
THTaHa
.n;HOKCH,ll,
MaKporon/PEG
3350,
JICUHTHH
(COCBblli)
0,26250
Mr,
:>KCJie3a
OKCH,ll KpaCHI:.lli,
:>KCJIC3a
OKCH,ll :>KCJITblli,
:>KCJIC3a
OKCH,ll
"t!CpHblli).
3 •
.JIEKAPCTBCIIHAH
4LOPMA:
Ta6neTKH
rrpOJIOHrHpOBaHHOrO ,llCHCTBIDI,
IIOKpbiThle
IIJICHO'lliOH
o60JIO"t!KOH.
4.
KNUUUQECKUE XAPAKTEPUCTHKH
4.1
TEPANEBTH'ICCKHE NOKAJAHHH
I10Ka3aHIDI
K rrpHMCHCHHIO
Kap.n;HonoriDI:
TpHMeTa3H.11:HH
noKa3aH
.n;IDI
npHMeHeHIDI
y
B3pocnr,Ix
B
KaqecTBe
.n:orronHHTenr,noH:
TepanHH
.n;ID1
npoqiHJiaKTHKH
H
CHMIITOMaTHqecKoro
JieqeHJUI 60JII:.HhlX
CO
CTa6HJibHOH CTCHOKap.n;HeH,
rrpncTyrri:.I
KOTOpOH KOHTpOJIHpYJOTCM Hea.n;eKBaTHO, HJIH
rrpn
HenepeHOCHMOCTH
rrperrapaTOB
rrepBOH JIHHHH aHTHaHI'HHaJII:.H:brli
Tepannn.
4.2
CNOCO6LI NPUMEHEHH.H U
)J.03HI
BHYfP,I.,
IIO
O,D;HOH
Ta6neTKe
35
Mr
2
pa3a
B
,lJ;CHb,
yTpOM
II
BeqepOM
BO
BpeMM
e,n;I:.I.
,ll;o3HpoBaHne
_B3pocJZbze: _
ITo
O,D;HOH
Ta6JieTKe
35
Mr
TpHMeTa3H.n;HHa
,D;Ba
pa3a
B
,lJ;CHb
BO
BpeMM e.n;bi.
Oco6I:.IerpyrrnhlnauHeHTOB
_llpwvteHeHue _
_y _
_naiJuenmoe c noliellnou _
_neoocmamollHOCmbJO: _
Y
nauneHTOB
c
YMepeHHOH
noqeqnoif
He,n;ocTaTO'lliOCTbiO
(KnnpeHc
KpeaTHHHHa
30-60
MJIIMnH)
(eM.
pa3.n;en
«0co6I>Ie
YKa3aHIDI» n
«apMaKoKnHeTnKa»
peKoMeH,n;OBaHHaJI ,n;03a
1
Ta6neTKa
35
Mr
yrpOM
BO BpeMM
3aBTpaKa).
_llpuMeHeHue _
_y _
_no;)ICWlblX _
_naiJuenmoe: _
Y
IIO:>KHJII.IX II
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Russian 08-05-2015